The Group is dedicated to advancing cutting-edge innovation that empowers physicians to deliver precise, minimally invasive cancer treatments and improve outcomes for cancer patients. By integrating robotics, AI and enabling remote procedures, the Precision IO Group aims to transform the standard of care in tumor ablation and interventional oncology procedures.
Quantum Surgical and NeuWave Medical, Inc. – both of which share an extensive focus on innovation to improve cancer patients’ outcomes – will operate as subsidiaries of Precision IO Group Inc., the newly created parent company led by medtech veteran Kurt Azarbarzin, who was recently appointed CEO.
Precision IO Group brings together two world-class companies with complementary technologies, expertise, and global capabilities in interventional oncology.
Recruiting Done Differently.
Improving lives by uniting great people with great companies.
We’re committed to sharing up-to-date industry insights, our newest career opportunities, and valuable tools to support you throughout your next job search. Let’s stay connected!
